Proqr website
WebbProQR Therapeutics NV is a clinical stage biopharmaceutical company. It is engaged in the discovery and development of RNA therapies for the treatment of severe genetic rare diseases with a focus on inherited retinal diseases, such as Leber congenital amaurosis 10, Usher syndrome type 2, and autosomal dominant retinitis pigmentosa. WebbProQR Therapeutics N.V. is registered at Zernikedreef 9, 2333 CK, in Leiden, the Netherlands. You can contact our Data Protection Officer (DPO) regarding any …
Proqr website
Did you know?
WebbPRQR's SEC filings can be seen here. And to visit PROQR THERAPEUTICS NV's official web site, go to www.proqr.com. PRQR Price Target For more insight on analysts targets of PRQR, see our PRQR price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page. Webb31 jan. 2024 · ProQR is committed to patient-focused drug development and recognizes the challenge of finding individuals with USH2A mediated retinitis pigmentosa. The Usher Syndrome Coalition has identified and is engaged with hundreds of potential candidates located near the proposed trial sites.
WebbChanging lives is what drives us at ProQR Therapeutics. We are advancing our proprietary Axiomer RNA-editing platform technology. Our highly energetic team strives to combine innovative... Webb7 mars 2024 · ProQR to Focus Exclusively on Axiomer RNA-editing Technology and Partner Ophthalmology Programs August 11, 2024 at 11:00 AM UTC ProQR Announces Second …
Webb11 aug. 2024 · ProQR will focus exclusively on the development of the Axiomer® RNA editing technology platform across multiple therapeutic areas. This comes following … WebbProQR Therapeutics Oct 2024 - Jun 20241 year 9 months Leiden, South Holland, Netherlands Santen 10 years 5 months Chief Science Officer, Head, Global R&D at Santen & Senior Corporate Officer May...
Webb18 nov. 2024 · LEIDEN, Netherlands & CAMBRIDGE, Mass., Nov. 04, 2024 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (the “Company”), a company …
Webb29 mars 2024 · At ProQR, we are passionate about pushing the boundaries of science and technology to create innovative solutions for unmet medical needs. Our team is … ProQR has offices in Leiden, the Netherlands and Cambridge, … At ProQR science is literally at the heart of what we do. The offices at our … ProQR is focused on the development of life changing RNA therapies for rare … Located in Leiden, Netherlands and Cambridge, Mass., ProQR Therapeutics … ProQR continues to honor his legacy through our mission of helping people … Jurriaan Dekkers, Chief Financial Officer. Jurriaan joined ProQR in 2024 as Chief … [email protected]. Media Inquiries. Robert Stanislaro FTI Consulting +1 212 850 … Find out where to (virtually) meet us in our events calendar. Here’s a list of … jean zombiWebb31 mars 2024 · The live and archived webcast of this presentation can be accessed through the Events and Presentations page on the Investors section of the Company’s website, www.ProQR.com. The dial-in... ladi meliWebb29 mars 2024 · ( Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through transformative RNA therapies based on its proprietary Axiomer® RNA editing technology platform, today announced initial pipeline programs focused on diseases that originate in … jean zuninoWebb19 dec. 2024 · ProQR Therapeutics: ClinicalTrials.gov Identifier: NCT03780257 Other Study ID Numbers: PQ-421a-001 2024-002433-38 ( EudraCT Number ) First Posted: December 19, 2024 Key Record Dates: Last Update Posted: April 20, 2024 Last Verified: April 2024 Individual Participant ... la dime obernai menuWebbProQR is a clinical stage biotech company based in the Netherlands that discovers and develops unique RNA-based therapies for severe genetic disorders. ProQR Announces … ladi meterWebbProQR promotes a solution: Producing SAF from renewable electricity, CO 2 and water from the ambient air. This so called Power-to-liquid (PtL) SAF is produced exactly where it is … jean zuriniWebb5 maj 2024 · ProQR is pioneering a next-generation RNA technology called Axiomer ®, which uses a cell’s own editing machinery called ADAR to make specific single … la dime obernai